Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
CompletedOBSERVATIONAL
Enrollment
2,000
Participants
Timeline
Start Date
April 17, 2002
Primary Completion Date
May 5, 2016
Conditions
Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1Adult Acute Promyelocytic Leukemia With PML-RARAChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid LeukemiaChildhood Acute Myeloid Leukemia in RemissionRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Acute Myeloid LeukemiaSecondary Acute Myeloid Leukemia
Interventions
OTHER
Laboratory Biomarker Analysis
Correlative studies
Trial Locations (1)
19104
Childrens Oncology Group, Philadelphia
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Children's Oncology Group
NETWORK
NCT01005277 - Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter